Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 35,000 shares at $190.00 ($6.7M) on 2015-12-24, disclosed to the SEC on 2015-12-29.
Scheduled sale ($6.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.00 | 5,632 | $1.1M | 16.0% |
| 2 | $190.15 | 400 | $76K | 1.1% |
| 3 | $190.55 | 16,882 | $3.2M | 48.2% |
| 4 | $191.14 | 12,086 | $2.3M | 34.6% |
| Total | $190.66 avg | 35,000 | $6.7M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |